CGC Research and Charts

CGC - Canopy Growth Corp (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2024-09-23 (Delayed quote data 2025-01-06)

Last 2.92	Change ⇓ -0.02 (-0.68%)	Volume 6,502,584
	Open 3.04	High 3.07	Low 2.91

8EMA (Daily) 2.88	40EMA (Daily) 3.43	50EMA (Daily) 3.60	STO (Daily) 33.370	MACD Hist (Daily) 0.089
8EMA (Weekly) 3.253	40EMA (Weekly) 4.61	50EMA (Weekly) 4.64	STO (Weekly) 5.743	MACD Hist (Weekly) -0.267


Company Profile
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.